Key facts
- This page summarizes Robert Nelsen's Form 4 filing for Denali Therapeutics Inc. (DNLI).
- 6 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jun 2021, 20:55.
Robert Nelsen - 22 Mar 2021 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)
- Reporting relationship
- Director
- Issuer ticker
- DNLI
- Reported as of
- 22 Mar 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jun 2021, 20:55:40 UTC
- Next SEC filing
- 25 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tyler Nielsen, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Nelsen filed Form 4 for Denali Therapeutics Inc. (DNLI) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNLI
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -500,000
- Change %
- -4.7%
- Price
- $0.000000
- Shares after
- 10,168,749
- Date
- 22 Mar 2021
- Ownership
- Held by ARCH Venture Fund VIII, L.P.
- Footnotes
- F1, F2, F3, F4
DNLI
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- -500,000
- Change %
- -4.9%
- Price
- $0.000000
- Shares after
- 9,668,749
- Date
- 12 May 2021
- Ownership
- Held by ARCH Venture Fund VIII, L.P.
- Footnotes
- F1, F2, F3, F5
DNLI
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +2,538
- Change %
- +125%
- Price
- $0.000000
- Shares after
- 4,568
- Date
- 22 Mar 2021
- Ownership
- Direct
- Footnotes
- F1, F2
DNLI
transaction
Common Stock
Other
- Transaction value
- $0
- Shares
- +2,537
- Change %
- +56%
- Price
- $0.000000
- Shares after
- 7,105
- Date
- 12 May 2021
- Ownership
- Direct
- Footnotes
- F1, F2
DNLI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,253
- Change %
- +46%
- Price
- $0.000000
- Shares after
- 10,358
- Date
- 01 Jun 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNLI
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -3,253
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,253
- Exercise price
- Footnotes
- F6, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Distribution of Common Stock held by a limited partnership to its partners for no consideration.
Footnote F2
Reflects change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
Footnote F3
The sole general partner of ARCH Venture Fund VIII, L.P. ("ARCH Fund VIII") is ARCH Venture Partners VIII, L.P. ("ARCH Partners VIII"). The sole general partner of ARCH Partners VIII is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"). ARCH Partners VIII may therefore be deemed to beneficially own the securities held by ARCH Fund VIII and ARCH VIII LLC may be deemed to beneficially own the securities held by ARCH Fund VIII. ARCH Partners VIII and ARCH VIII LLC disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein. The Reporting Person is a managing director of ARCH VIII LLC and may be deemed to beneficially own the shares held by ARCH Fund VIII. Mr. Nelsen disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
Footnote F4
Following the reported transactions, 10,168,749 shares of common stock were held of record by ARCH Fund VIII.
Footnote F5
Following the reported transactions, 9,668,749 shares of common stock were held of record by ARCH Fund VIII.
Footnote F6
Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Footnote F7
100% of the restricted stock units shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.